RecruitingNot ApplicableNCT06799390

Auricular VNS Following Intracerebral Hemorrhage

Vagus Nerve Stimulation Following Intracerebral Hemorrhage (IHC) to Mitigate ICH-induced Inflammation and Cerebral Edema

Sponsor

Washington University School of Medicine

Enrollment

80 participants

Start Date

Apr 6, 2025

Study Type

INTERVENTIONAL

Conditions

Intracerebral Hemorrhage

Summary

This study will evaluate whether non-invasive auricular vagal nerve stimulation lowers inflammatory markers, and improves outcomes following intracerebral hemorrhage.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Auricular Vagus Nerve Stimulation and a medical device called Sham Auricular Vagus nerve Stimulation for people with intracerebral hemorrhage. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEAuricular Vagus Nerve Stimulation

Transcutaneous auricular vagal nerve stimulation

DEVICESham Auricular Vagus nerve Stimulation

Transcutaneous auricular vagal nerve ear clip applied without current

Locations(1)

Washington University School of Medicine

St Louis, Missouri, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06799390

Related Trials

Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage

NCT0640296818 locations

The Fifth INTEnsive pReventing Secondary Injury in Acute Cerebral Haemorrhage Trial Within ACT-GLOBAL

NCT067630552 locations